• Nvidia (NasdaqGS:NVDA) has agreed to invest a combined US$4b in Lumentum and Coherent to support advanced optics for next generation AI data centers.
• The multiyear partnerships aim to expand R&D and US manufacturing capacity for optical components used in high performance AI infrastructure.
• Telecom players including Tech Mahindra, Nokia, LITEON, and Keysight are rolling out Nvidia powered AI RAN solutions to automate and optimize networks.
• Droplet Biosciences is using Nvidia AI infrastructure to deliver genomic test results much faster than prior workflows.

You are looking at Nvidia at a moment when its chip business is tightly linked to how AI data centers are physically built. The new US$4b optics commitments highlight the importance of securing key components for what the company describes as gigawatt scale AI factories. At the same time, telecom and genomics partners are showing how Nvidia’s platform is used in real world workloads beyond training large AI models.

For investors, the combination of supply chain commitments and commercial deployments provides more context around Nvidia’s role in AI infrastructure, not just its flagship GPUs. As you read on, consider how these moves could influence the breadth of Nvidia’s ecosystem, its relationships with manufacturers and customers, and the kinds of workloads that may drive demand for its hardware and software stack.

Stay updated on the most important news stories for NVIDIA by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on NVIDIA.

Nvidia’s US$4b combined investment in Lumentum and Coherent ties directly to a practical constraint in AI data centers, which is moving data quickly and efficiently between chips. By securing future supply and capacity rights for advanced optical components, Nvidia is effectively pre-booking a key ingredient for its so-called AI factories. That is important when hyperscalers and governments are planning very large GPU clusters and need confidence that networking and optics will not become the bottleneck.

On the demand side, telecom and genomics use cases highlight how Nvidia is trying to ensure its platform is used across varied workloads, not only foundation model training. Tech Mahindra’s AI-powered network operations agent, Nokia’s AI-RAN work, and Keysight’s testbed all rely on Nvidia’s AI software and hardware to automate and validate networks. Droplet Biosciences shows a similar pattern in healthcare, using Nvidia’s Parabricks software and GPUs to cut genomic analysis times from days to hours and reduce cost per sample.

How This Fits Into The NVIDIA Narrative

• The Lumentum and Coherent deals support the existing narrative that Nvidia is building full-stack AI infrastructure, from GPUs to networking, to underpin multi-year AI data center investment.
• Locking in multibillion-dollar purchase commitments and capacity rights could challenge the narrative if AI infrastructure spending slows, because long-term obligations might weigh on flexibility and margins.
• The telecom and genomics partnerships, such as AI-RAN deployments and GPU-accelerated clinical genomics, broaden real-world usage that is not fully captured in a narrative focused mainly on hyperscaler data centers.

Knowing what a company is worth starts with understanding its story. Check out one of the top narratives in the Simply Wall St Community for NVIDIA to help decide what it's worth to you.

The Risks and Rewards Investors Should Consider

• ⚠️ Analysts have flagged that Nvidia’s earnings quality includes a high level of non cash items, which can make it harder to compare reported profit to underlying cash generation when the company is also taking on large supply commitments.
• ⚠️ Large, multi year purchase and capacity agreements in optics add to existing supply obligations, so if AI data center demand or customer spending plans change, Nvidia could face pressure on margins or inventory.
• 🎁 Nvidia is currently trading on a P/E that analysts see as below the broader semiconductor industry average, while earnings are forecast to grow at more than 20% per year, which some investors view as a favorable risk reward profile.
• 🎁 Partnerships across telecom, genomics and other sectors show that Nvidia’s GPUs and software are being adopted for more than one type of AI workload, which can support diversified revenue sources over time.

What To Watch Going Forward

After these announcements, it is worth watching how quickly Lumentum and Coherent convert Nvidia’s funding into usable optical capacity for next generation data centers, and whether those parts show up in reference architectures for Blackwell, Rubin and follow-on platforms. On the demand side, pay attention to how AI-RAN pilots with Nokia, Tech Mahindra and LITEON progress from trials to scaled deployments, and whether healthcare users like Droplet Biosciences move from case studies to broader rollouts. Investors may also track any future commentary from Nvidia on the size of its long term purchase obligations and how those compare with contracted demand from cloud, sovereign AI and enterprise customers.

To ensure you're always in the loop on how the latest news impacts the investment narrative for NVIDIA, head to the community page for NVIDIA to never miss an update on the top community narratives.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.